Hepatitis C Treatment Options

Once a person has had the diagnosis confirmed that they are infected with Hepatitis C there are treatment options that must be considered. At one time it was believed that if the infection was still in its acute stage, meaning the person had been infected for less then six months, no treatment should be used. Physicians hoped that if left alone it would go away. So they did nothing. Research has changed this analysis.  Now they work vigorously through all stages of Hepatitis C to do the best they can to treat the infection. But the kind of treatment they offer depends a lot on what age the patient is more than just the stage of infection that they are in.

A child will be given a treatment of interferon with no accompanying medication. If they are still in the acute stage the success rate is seventy percent.  Though researchers are still trying to understand why this treatment works so well in children parents are grateful for the high success rate. There is more confusion in treating children than in adults.  Studies are continuing to better understand why a higher portion of children can clear the infection out of there systems without treatment than adults can.

Seniors are another treatment issue. When someone over sixty becomes infected physicians do not suggest using any treatment.  This is because the progress of Hepatitis C to serious liver damage, cirrhosis of the liver, can take anywhere from twenty to forty years. Therefore it is felt that a person of that age will more likely die of natural causes in their old age than anything connected with the Hepatitis C virus.  There will be some common sense lifestyle changes but beyond that more regular check-ups are about all that needs to be done.

Anyone who does not fall into those age restrictions has more treatment options. Interferon is the medication used most often to treat the Hepatitis C virus.  Use of this medication alone has a cure rate of twenty five percent. That means the infection comes under control.  Unfortunately sometimes patients have a relapse and if so this calls for a drug therapy that combines interferon with ribavirin.  This double hitting drug therapy has some good results with forty five percent of patients using this combination showing diminished levels of the virus. Neither of these should be used if a woman is pregnant as it can cause defects or death of the fetus. Don't let the side effects prevent you from taking the treatment.

Anyone who is being treated for Hepatitis C should do a few things to help their health.  One of the most important is to stop drinking. Alcohol will only speed along the damage to a person's liver. Do not use any new over the counter medications or try any natural or herbal remedies without first talking to your health care provider. Ask about getting vaccinated for both Hepatitis A nd B, especially if there are already some signs of liver damage.

Hepatitis news on the Web

Hepatitis Research May Benefit From Stem Cells
Hepatitis C is a viral disease that leads to inflammation and organ failure. However, researchers are puzzled as to why some individuals are very susceptible to the disease, while others are not. Researchers believe they could find out how genetic variations produce these different responses by investigating liver cells from different individuals in the lab. However, liver cells are hard to ...

Gilead Sciences jumps on hepatitis C data
Shares of Gilead Sciences Inc. jumped Friday after the company reported further progress of GS-7977, a newly-acquired hepatitis C treatment still in clinical testing.THE SPARK: Gilead said Thursday that ...

Gilead Rises on Hepatitis C Trial Results: San Francisco Mover
Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc. last month for its experimental hepatitis C treatments, gained the most in three years after one of the medicines produced positive clinical trial results.

Township hosting hepatitis B vaccine clinics
WEST MILFORD Hepatitis is one of the most harmful diseases one can have, many times leading into liver cancer years down the road. The West Milford Health Department is promoting a series of three hepatitis B vaccines to protect your liver from this devastating disease.

Gilead Gains on Positive Data From Experimental Hepatitis C Drug
Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc. last month for its experimental hepatitis C treatments, gained in extended trading after saying one of the therapies produced positive clinical trial results.

Stem cells could drive hepatitis research forward
Researchers have produced liver-like cells from induced pluripotent stem cells. By creating liver-like cells, scientists can study why people respond differently to Hepatitis C.

Stem Cells May Further Hepatitis C Research
Title: Stem Cells May Further Hepatitis C Research Category: Health News Created: 1/31/2012 4:05:00 PM Last Editorial Review: 2/1/2012

U.S. hepatitis A vaccine rates vary widely, survey shows
NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC). In certain states, particularly those in the south, midwest and eastern U.S., those rates are lower -- with about three kids out of 10 ...

Research and Markets: Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016
Research and Markets has announced the addition of the "Hepatitis C Market Forecast & Drugs Pipeline A

Hepatitis C treatment with antivirals is effective
A major advance in treating hepatitis C appears to be on the horizon. Researchers reported Wednesday that combining two antiviral medications was effective in stopping the infection in some patients who were not helped by the traditional treatment.